National Institute for Health Research
Health Services and Delivery Research Programme
- Award winner: Jill Manthorpe
- Institution: King’s College London
- Value: £348,729
Service provision for older people who are homeless and have memory problems
Public Health Research Programme
- Award winner: Gene Feder
- Institution: University of Bristol
- Value: £193,912
An overview of interventions aimed at improving outcomes for children exposed to domestic violence
- Award winner: Nicky Stanley
- Institution: University of Central Lancashire
- Value: £161,978
Scoping the evidence on preventive interventions in domestic abuse for children and young people in the general population
Leverhulme Trust
Research Project Grants
Social sciences
- Award winner: Anthony Musson
- Institution: University of Exeter
- Value: £178,371
Law and arms: the English medieval Court of Chivalry
Philip Leverhulme Prizes
Law
- Award winner: Ioannis Lianos
- Institution: University College London
- Value: £70,000
The interaction of economic thought with the legal system
Mathematics and statistics
- Award winner: Christoph Ortner
- Institution: University of Warwick
- Value: £70,000
Numerical analysis and applied analysis
- Award winner: Lasse Rempe-Gillen
- Institution: University of Liverpool
- Value: £70,000
Complex dynamics
Medieval, early modern and modern history
- Award winner: Sadiah Qureshi
- Institution: University of Birmingham
- Value: £70,000
Modern history of race, empire and science
Arts and Humanities Research Council
Responsive Mode Grants
- Award winner: Aaron Williamon
- Institution: Royal College of Music
- Value: £802,739
Musical impact: A study of the effects of music-making on musicians’ health and well-being
- Award winner: David Parsons
- Institution: University of Wales
- Value: £774,581
The cult of saints in Wales: medieval Welsh-language sources and their transmission
In detail
Efficacy and Mechanism Evaluation Programme
Award winner: Sven Plein
Institution: University of Leeds
Value: £589,199
Coronary artery disease evaluation in rheumatoid arthritis
Rheumatoid arthritis causes disabling joint changes, but also leads to other ailments (co-morbidities), of which heart disease is the most important and risky. The reason for this excess risk is thought to be widespread inflammation in the body. Newer treatments for rheumatoid arthritis effectively suppress inflammation in the joints, and it has been speculated that these treatments may also suppress the co-morbidities, particularly reducing the risk of heart disease. The team will use magnetic resonance imaging to detect early signs of heart disease in patients with a new diagnosis of rheumatoid arthritis and to test whether these changes are reversible with effective treatments of inflammation called biologics. If such effects can be shown, the management of rheumatoid arthritis could be changed to introduce biologics.